# Official Journal C 203/2007

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 203 |
| | |
| English edition | Information and Notices | Volume 5031 August 2007 |

ISSN 1725-2423

Official Journal

of the European Union

C 203

English edition

Information and Notices

Volume 5031 August 2007

---

| Notice No | Contents | page |
| --- | --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
| | Commission |
| 2007/C 203/01 | Non-opposition to a notified concentration (Case COMP/M.4688 — Nestlé/Gerber) (
  1
  ) | 1 |

Notice No

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

2007/C 203/01

Non-opposition to a notified concentration (Case COMP/M.4688 — Nestlé/Gerber) (
  1
  )

1

1

| | IV   Notices |
| --- | --- |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES |
| | Commission |
| 2007/C 203/02 | Euro exchange rates | 2 |
| 2007/C 203/03 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2007 to 31 July 2007(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  ) | 3 |
| 2007/C 203/04 | Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2007 to 31 July 2007(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  ) | 10 |

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

2007/C 203/02

Euro exchange rates

2

2007/C 203/03

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2007 to 31 July 2007(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
  )

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council

)

3

2007/C 203/04

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2007 to 31 July 2007(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
  )

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council

or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council

)

10

| | V   Announcements |
| --- | --- |
| | ADMINISTRATIVE PROCEDURES |
| | European Parliament |
| 2007/C 203/05 | Recruitment notice PE/110/S | 14 |
| | PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION POLICY |
| | Commission |
| 2007/C 203/06 | Notice from the Government of Romania concerning Directive 94/22/EC of the European Parliament and of the Council on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons (
  1
  ) | 15 |
| 2007/C 203/07 | Prior notification of a concentration (Case COMP/M.4866 — Arques/Actebis) (
  1
  ) | 25 |
| 2007/C 203/08 | Prior notification of a concentration (Case COMP/M.4713 — Aviva/Hamilton) (
  1
  ) | 26 |

V   Announcements

ADMINISTRATIVE PROCEDURES

European Parliament

2007/C 203/05

Recruitment notice PE/110/S

14

PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION POLICY

Commission

2007/C 203/06

Notice from the Government of Romania concerning Directive 94/22/EC of the European Parliament and of the Council on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons (
  1
  )

1

15

2007/C 203/07

Prior notification of a concentration (Case COMP/M.4866 — Arques/Actebis) (
  1
  )

1

25

2007/C 203/08

Prior notification of a concentration (Case COMP/M.4713 — Aviva/Hamilton) (
  1
  )

1

26

| | |
| --- | --- |
| | (1)   Text with EEA relevance |

---

(1)   Text with EEA relevance

1

| EN | |
| --- | --- |

EN

---

II Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

| 31.8.2007 | EN | Official Journal of the European Union | C 203/1 |
| --- | --- | --- | --- |

31.8.2007

EN

Official Journal of the European Union

C 203/1

---

Non-opposition to a notified concentration

(Case COMP/M.4688 — Nestlé/Gerber)

(Text with EEA relevance)

(2007/C 203/01)

On 27 July 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32007M4688. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32007M4688. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu)

---

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS AND BODIES

Commission

| 31.8.2007 | EN | Official Journal of the European Union | C 203/2 |
| --- | --- | --- | --- |

31.8.2007

EN

Official Journal of the European Union

C 203/2

---

Euro exchange rates (1)

30 August 2007

(2007/C 203/02)

1 euro=

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,3610 |
| JPY | Japanese yen | 157,33 |
| DKK | Danish krone | 7,4472 |
| GBP | Pound sterling | 0,67800 |
| SEK | Swedish krona | 9,3832 |
| CHF | Swiss franc | 1,6402 |
| ISK | Iceland króna | 86,71 |
| NOK | Norwegian krone | 7,9590 |
| BGN | Bulgarian lev | 1,9558 |
| CYP | Cyprus pound | 0,5842 |
| CZK | Czech koruna | 27,594 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 255,44 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,6974 |
| MTL | Maltese lira | 0,4293 |
| PLN | Polish zloty | 3,8271 |
| RON | Romanian leu | 3,2616 |
| SKK | Slovak koruna | 33,740 |
| TRY | Turkish lira | 1,7943 |
| AUD | Australian dollar | 1,6677 |
| CAD | Canadian dollar | 1,4454 |
| HKD | Hong Kong dollar | 10,6142 |
| NZD | New Zealand dollar | 1,9404 |
| SGD | Singapore dollar | 2,0761 |
| KRW | South Korean won | 1 280,02 |
| ZAR | South African rand | 9,7932 |
| CNY | Chinese yuan renminbi | 10,2633 |
| HRK | Croatian kuna | 7,3212 |
| IDR | Indonesian rupiah | 12 820,62 |
| MYR | Malaysian ringgit | 4,7689 |
| PHP | Philippine peso | 63,695 |
| RUB | Russian rouble | 34,9280 |
| THB | Thai baht | 44,344 |

Currency

Exchange rate

USD

US dollar

1,3610

JPY

Japanese yen

157,33

DKK

Danish krone

7,4472

GBP

Pound sterling

0,67800

SEK

Swedish krona

9,3832

CHF

Swiss franc

1,6402

ISK

Iceland króna

86,71

NOK

Norwegian krone

7,9590

BGN

Bulgarian lev

1,9558

CYP

Cyprus pound

0,5842

CZK

Czech koruna

27,594

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

255,44

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,6974

MTL

Maltese lira

0,4293

PLN

Polish zloty

3,8271

RON

Romanian leu

3,2616

SKK

Slovak koruna

33,740

TRY

Turkish lira

1,7943

AUD

Australian dollar

1,6677

CAD

Canadian dollar

1,4454

HKD

Hong Kong dollar

10,6142

NZD

New Zealand dollar

1,9404

SGD

Singapore dollar

2,0761

KRW

South Korean won

1 280,02

ZAR

South African rand

9,7932

CNY

Chinese yuan renminbi

10,2633

HRK

Croatian kuna

7,3212

IDR

Indonesian rupiah

12 820,62

MYR

Malaysian ringgit

4,7689

PHP

Philippine peso

63,695

RUB

Russian rouble

34,9280

THB

Thai baht

44,344

---

(1)

Source: reference exchange rate published by the ECB.

---

| 31.8.2007 | EN | Official Journal of the European Union | C 203/3 |
| --- | --- | --- | --- |

31.8.2007

EN

Official Journal of the European Union

C 203/3

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2007 to 31 July 2007

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council
   (1)
  )

(2007/C 203/03)

—   Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN
  (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code
  (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 20.7.2007 | MIRCERA | methoxy polyethylene glycol-epoetin beta | Roche Registration Limited |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Date of the decision

Name of the medicinal product

INN

(International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code

(Anatomical Therapeutic Chemical Code)

Date of notification

20.7.2007

MIRCERA

methoxy polyethylene glycol-epoetin beta

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/07/400/001-016

Solution for injection

B03XA03

25.7.2007

23.7.2007

Orlistat GSK

Orlistat

| Glaxo Group Limited |
| --- |
| Berkeley Avenue |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Limited

Berkeley Avenue

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/07/401/001-006

Capsule, hard

A08AB01

25.7.2007

23.7.2007

OptiMARK

Gadoversetamide

| Tyco Healthcare Deutschland GmbH |
| --- |
| Gewerbepark 1 |
| D-93333 Neustadt/Donau |

Tyco Healthcare Deutschland GmbH

Gewerbepark 1

D-93333 Neustadt/Donau

EU/1/07/398/001-014

Solution for injection

V08CA06

25.7.2007

30.7.2007

Aerinaze

desloratadine/pseudoephedrine sulphate

| SP Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

SP Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/07/399/001-006

Release tablet

R06A X27

1.8.2007

—   Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 2.7.2007 | Cellcept | Roche Registration Limited |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

2.7.2007

Cellcept

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/96/005/001-006

5.7.2007

2.7.2007

Apidra

| Sanofi-Aventis Deutschland GmbH |
| --- |
| Brueningstraße 50 |
| D-65926 Frankfurt am Main |

Sanofi-Aventis Deutschland GmbH

Brueningstraße 50

D-65926 Frankfurt am Main

EU/1/04/285/001-036

5.7.2007

2.7.2007

Exjade

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/06/356/001-006

5.7.2007

2.7.2007

Telzir

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/04/282/001-002

5.7.2007

2.7.2007

Aptivus

| Boehringer Ingelheim International GmbH |
| --- |
| Binger Straße 173 |
| D-55216 Ingelheim am Rhein |

Boehringer Ingelheim International GmbH

Binger Straße 173

D-55216 Ingelheim am Rhein

EU/1/05/315/001

5.7.2007

2.7.2007

Stocrin

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/99/111/001-011

5.7.2007

2.7.2007

Sustiva

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge UD8 1DH |
| United Kingdom |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge UD8 1DH

United Kingdom

EU/1/99/110/001-009

5.7.2007

2.7.2007

Naglazyme

| BioMarin Europe Limited |
| --- |
| Axtell House |
| 23-24 Warwick Street |
| London W1B 5NQ |
| United Kingdom |

BioMarin Europe Limited

Axtell House

23-24 Warwick Street

London W1B 5NQ

United Kingdom

EU/1/05/324/001

5.7.2007

3.7.2007

Ammonaps

| Swedish Orphan International AB |
| --- |
| Drottninggatan 98 |
| S-111 60 Stockholm |

Swedish Orphan International AB

Drottninggatan 98

S-111 60 Stockholm

EU/1/99/120/003-004

5.7.2007

9.7.2007

Zyprexa

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/96/022/002

EU/1/96/022/004

EU/1/96/022/006

EU/1/96/022/008-012

EU/1/96/022/014

EU/1/96/022/016-017

EU/1/96/022/019-034

11.7.2007

9.7.2007

Avonex

| Biogen Idec Ltd |
| --- |
| 5 Roxborough Way |
| Foundation Park |
| Maidenhead |
| Berkshire SL6 3UD |
| United Kindgom |

Biogen Idec Ltd

5 Roxborough Way

Foundation Park

Maidenhead

Berkshire SL6 3UD

United Kindgom

EU/1/97/033/002-004

11.7.2007

9.7.2007

Rebetol

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/99/107/001-005

11.7.2007

9.7.2007

IntronA

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/99/127/001-044

11.7.2007

9.7.2007

Simulect

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/98/084/001-002

11.7.2007

9.7.2007

Vfend

| Pfizer Ltd |
| --- |
| Ramsgate Road |
| Sandwich |
| Kent CT 13 9NJ |
| United Kingdom |

Pfizer Ltd

Ramsgate Road

Sandwich

Kent CT 13 9NJ

United Kingdom

EU/1/02/212/001-026

11.7.2007

16.7.2007

Neupopeg

| Dompé Biotec S.p.A. |
| --- |
| Via San Martino, 12 |
| I-20122 Milano |

Dompé Biotec S.p.A.

Via San Martino, 12

I-20122 Milano

EU/1/02/228/001-003

18.7.2007

16.7.2007

Neulasta

| Amgen Europe B.V. |
| --- |
| Minervum 7061 |
| 4817 ZK Breda |
| Nederland |

Amgen Europe B.V.

Minervum 7061

4817 ZK Breda

Nederland

EU/1/02/227/001-003

18.7.2007

20.7.2007

Xigris

| Eli Lilly Nederland B.V. |
| --- |
| Grootslag 1-5 |
| 3991 RA Houten |
| Nederland |

Eli Lilly Nederland B.V.

Grootslag 1-5

3991 RA Houten

Nederland

EU/1/02/225/001-002

27.7.2007

20.7.2007

Optison

| GE Healthcare AS |
| --- |
| Nycoveien 1-2 |
| P.O.Box 4220 Nydalen |
| N-0401 Oslo |

GE Healthcare AS

Nycoveien 1-2

P.O.Box 4220 Nydalen

N-0401 Oslo

EU/1/98/065/001-002

26.7.2007

20.7.2007

Prialt

| Eisai Limited, 3 |
| --- |
| Shortlands |
| London W6 8EE |
| United Kingdom |

Eisai Limited, 3

Shortlands

London W6 8EE

United Kingdom

EU/1/04/302/001-004

25.7.2007

20.7.2007

REYATAZ

| Bristol-Myers Squibb Pharma EEIG |
| --- |
| Uxbridge Business Park |
| Sanderson Road |
| Uxbridge UD8 1DH |
| United Kingdom |

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park

Sanderson Road

Uxbridge UD8 1DH

United Kingdom

EU/1/03/267/001-007

25.7.2007

23.7.2007

Trisenox

| Cephalon Europe |
| --- |
| 5, Rue Charles Martigny |
| F-94700 Maisons Alfort, Cedex |

Cephalon Europe

5, Rue Charles Martigny

F-94700 Maisons Alfort, Cedex

EU/1/02/204/001

25.7.2007

24.7.2007

RotaTeq

| Sanofi Pasteur MSD SNC |
| --- |
| 8, rue Jonas Salk |
| F-69007 Lyon |

Sanofi Pasteur MSD SNC

8, rue Jonas Salk

F-69007 Lyon

EU/1/06/348/001-002

26.7.2007

24.7.2007

Zostavax

| Sanofi Pasteur MSD SNC |
| --- |
| 8, rue Jonas Salk |
| F-69007 Lyon |

Sanofi Pasteur MSD SNC

8, rue Jonas Salk

F-69007 Lyon

EU/1/06/341/001-013

26.7.2007

24.7.2007

Crixivan

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/96/024/001-005

EU/1/96/024/007-008

EU/1/96/024/010

26.7.2007

24.7.2007

Telzir

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/04/282/001-002

26.7.2007

24.7.2007

Prezista

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg, 30 |
| B-2340 Beerse |

Janssen-Cilag International NV

Turnhoutseweg, 30

B-2340 Beerse

EU/1/06/380/001

26.7.2007

24.7.2007

Tarceva

| Roche Registration Limited |
| --- |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

EU/1/05/311/001-003

26.7.2007

24.7.2007

Twinrix Adult

| GlaxoSmithKline Biologicals s.a. |
| --- |
| rue de l'Institut 89 |
| B-1330 Rixensart |

GlaxoSmithKline Biologicals s.a.

rue de l'Institut 89

B-1330 Rixensart

EU/1/96/020/001-009

26.7.2007

24.7.2007

Onsenal

| Pharmacia-Pfizer EEIG |
| --- |
| Ramsgate Road |
| Sandwich CT13 9NJ |
| United Kingdom |

Pharmacia-Pfizer EEIG

Ramsgate Road

Sandwich CT13 9NJ

United Kingdom

EU/1/03/259/001-006

27.7.2007

24.7.2007

Helixate NexGen

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

EU/1/00/144/001-003

27.7.2007

24.7.2007

KOGENATE Bayer

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

EU/1/00/143/001-009

27.7.2007

24.7.2007

Preotact

| Nycomed Danmark ApS |
| --- |
| Langebjerg 1 |
| DK-4000 Roskilde |

Nycomed Danmark ApS

Langebjerg 1

DK-4000 Roskilde

EU/1/06/339/001-002

27.7.2007

24.7.2007

Remicade

| Centocor B.V. |
| --- |
| Einsteinweg 101 |
| 2333 CB Leiden |
| Nederland |

Centocor B.V.

Einsteinweg 101

2333 CB Leiden

Nederland

EU/1/99/116/001-003

27.7.2007

24.7.2007

Gardasil

| Sanofi Pasteur MSD SNC |
| --- |
| 8, rue Jonas Salk |
| F-69007 Lyon |

Sanofi Pasteur MSD SNC

8, rue Jonas Salk

F-69007 Lyon

EU/1/06/357/001-017

27.7.2007

24.7.2007

Silgard

| Merck Sharp & Dohme Ltd |
| --- |
| Hertford Road |
| Hoddesdon |
| Hertfordshire EN11 9BU |
| United Kingdom |

Merck Sharp & Dohme Ltd

Hertford Road

Hoddesdon

Hertfordshire EN11 9BU

United Kingdom

EU/1/06/358/001-017

27.7.2007

24.7.2007

ReFacto

| Wyeth Europa Ltd |
| --- |
| untercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire SL6 0PH |
| United Kingdom |

Wyeth Europa Ltd

untercombe Lane South

Taplow

Maidenhead

Berkshire SL6 0PH

United Kingdom

EU/1/99/103/001-004

27.7.2007

24.7.2007

Advate

| Baxter AG |
| --- |
| Industriesstrasse 67 |
| A-1220 Vienna |

Baxter AG

Industriesstrasse 67

A-1220 Vienna

EU/1/03/271/001-004

27.7.2007

25.7.2007

Rapamune

| Wyeth Europa Limited |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire SL6 0PH |
| United Kingdom |

Wyeth Europa Limited

Huntercombe Lane South

Taplow

Maidenhead

Berkshire SL6 0PH

United Kingdom

EU/1/01/171/001

EU/1/01/171/007-012

30.7.2007

25.7.2007

Kaletra

| Abbott laboratories Ltd |
| --- |
| Queenborough |
| Kent ME11 5EL |
| United Kingdom |

Abbott laboratories Ltd

Queenborough

Kent ME11 5EL

United Kingdom

EU/1/01/172/001-005

30.7.2007

25.7.2007

Temodal

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/98/096/001-012

30.7.2007

25.7.2007

Aclasta

| Novartis Europharm Limited |
| --- |
| Wimblehurst Road |
| Horsham |
| West Sussex RH12 5AB |
| United Kingdom |

Novartis Europharm Limited

Wimblehurst Road

Horsham

West Sussex RH12 5AB

United Kingdom

EU/1/05/308/001-002

30.7.2007

25.7.2007

Agenerase

| Glaxo Group Ltd |
| --- |
| Greenford Road |
| Greenford |
| Middlesex UB6 0NN |
| United Kingdom |

Glaxo Group Ltd

Greenford Road

Greenford

Middlesex UB6 0NN

United Kingdom

EU/1/00/148/001-004

30.7.2007

30.7.2007

BeneFix

| Wyeth Europa Ltd |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire SL6 0PH |
| United Kingdom |

Wyeth Europa Ltd

Huntercombe Lane South

Taplow

Maidenhead

Berkshire SL6 0PH

United Kingdom

EU/1/97/047/004-007

1.8.2007

30.7.2007

Velcade

| Janssen-Cilag International NV |
| --- |
| Turnhoutseweg, 30 |
| B-2340 Beerse |

Janssen-Cilag International NV

Turnhoutseweg, 30

B-2340 Beerse

EU/1/04/274/001

1.8.2007

30.7.2007

Suboxone

| Schering Plough Europe |
| --- |
| Rue de Stalle, 73 |
| B-1180 Bruxelles |
| Stallestraat, 73 |
| B-1180 Brussel |

Schering Plough Europe

Rue de Stalle, 73

B-1180 Bruxelles

Stallestraat, 73

B-1180 Brussel

EU/1/06/359/001-004

1.8.2007

30.7.2007

Prevenar

| Wyeth-Lederle Vaccines S.A. |
| --- |
| Rue du Bosquet, 15 |
| B-1348 Louvain-La-Neuve |

Wyeth-Lederle Vaccines S.A.

Rue du Bosquet, 15

B-1348 Louvain-La-Neuve

EU/1/00/167/001-007

1.8.2007

30.7.2007

Axura

| Merz Pharmaceuticals GmbH |
| --- |
| Eckenheimer Landstr. 100-104 |
| D-60318 Frankfurt/Main |

Merz Pharmaceuticals GmbH

Eckenheimer Landstr. 100-104

D-60318 Frankfurt/Main

EU/1/02/218/001-011

2.8.2007

—   Withdrawal of a marketing authorization (Article 13 of Regulation (EC) No 726/2004)

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 9.7.2007 | Trudexa | Abbott laboratories Ltd |
| Queenborough |
| Kent ME11 5EL |
| United Kingdom |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

9.7.2007

Trudexa

Abbott laboratories Ltd

Queenborough

Kent ME11 5EL

United Kingdom

EU/1/03/257/001-010

11.7.2007

—   Issuing of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | INN
  (International Non-Proprietary Name) | Holder of the marketing authorization | Number of the entry in the Community Register | Pharmaceutical form | ATC code
  (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 10.7.2007 | Suprelorin | Deslorelin acetate | Cyton Biosciences Ltd |
| Hyland Mews |
| 21 High Street |
| Clifton |
| Bristol BS8 2YF |
| United Kingdom |

Date of the decision

Name of the medicinal product

INN

(International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code

(Anatomical Therapeutic Chemical Code)

Date of notification

10.7.2007

Suprelorin

Deslorelin acetate

Cyton Biosciences Ltd

Hyland Mews

21 High Street

Clifton

Bristol BS8 2YF

United Kingdom

EU/2/07/072/001-002

Implant

QH01CA93

12.7.2007

—   Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004): Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorization | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 16.7.2007 | ProteqFlu | Merial |
| 29, Avenue Tony Garnier |
| F-69007 Lyon |

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

16.7.2007

ProteqFlu

Merial

29, Avenue Tony Garnier

F-69007 Lyon

EU/2/03/037/005

18.7.2007

16.7.2007

Advocate

| Bayer HealthCare AG |
| --- |
| D-51368 Leverkusen |

Bayer HealthCare AG

D-51368 Leverkusen

EU/2/03/039/019-030

18.7.2007

24.7.2007

ProMeris Duo

| Fort Dodge Animal Health Holland |
| --- |
| C.J. van Houtenlaan 36 |
| 1381 CP Weesp |
| Nederland |

Fort Dodge Animal Health Holland

C.J. van Houtenlaan 36

1381 CP Weesp

Nederland

EU/2/06/065/001-010

26.7.2007

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

The European Medicines Agency

| 7, Westferry Circus |
| --- |
| Canary Wharf |
| London E14 4HB |
| United Kingdom |

7, Westferry Circus

Canary Wharf

London E14 4HB

United Kingdom

---

(1)  OJ L 136, 30.4.2004, p. 1.

---

| 31.8.2007 | EN | Official Journal of the European Union | C 203/10 |
| --- | --- | --- | --- |

31.8.2007

EN

Official Journal of the European Union

C 203/10

---

Summary of Community decisions on marketing authorizations in respect of medicinal products from 1 July 2007 to 31 July 2007

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC of the European Parliament and of the Council
   (1)
  or Article 38 of Directive 2001/82/EC of the European Parliament and of the Council
   (2)
  )

(2007/C 203/04)

—   Issuing, maintenance or modification of a national marketing authorisation

| Date of the decision | Name(s) of the medicinal product | Holder(s) of the marketing authorization | Member State concerned | Date of notification |
| --- | --- | --- | --- | --- |
| 10.7.2007 | Enurace 50 | See Annex I | See Annex I | 11.7.2007 |
| 11.7.2007 | Ciprofloxacin Hikma | See Annex II | See Annex II | 12.7.2007 |
| 20.7.2007 | MIRCERA | Roche Registration Limited |
| 6 Falcon Way |
| Shire Park |
| Welwyn Garden City AL7 1TW |
| United Kingdom |

Date of the decision

Name(s) of the medicinal product

Holder(s) of the marketing authorization

Member State concerned

Date of notification

10.7.2007

Enurace 50

See Annex I

See Annex I

11.7.2007

11.7.2007

Ciprofloxacin Hikma

See Annex II

See Annex II

12.7.2007

20.7.2007

MIRCERA

Roche Registration Limited

6 Falcon Way

Shire Park

Welwyn Garden City AL7 1TW

United Kingdom

This Decision is addressed to the Member States

24.7.2007

30.7.2007

BeneFix

| Wyeth Europa Ltd |
| --- |
| Huntercombe Lane South |
| Taplow |
| Maidenhead |
| Berkshire SL6 0PH |
| United Kingdom |

Wyeth Europa Ltd

Huntercombe Lane South

Taplow

Maidenhead

Berkshire SL6 0PH

United Kingdom

This Decision is addressed to the Member States

31.7.2007

30.7.2007

Vantas

See Annex III

See Annex III

31.7.2007

---

(1)  OJ L 311, 28.11.2001, p. 67.

(2)  OJ L 311, 28.11.2001, p. 1.

---

ANNEX I

NAME, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ANIMAL SPECIES, ROUTES OF ADMINISTRATION AND MARKETING AUTHORISATION HOLDER

| Member State | Applicant or Marketing Authorisation Holder | Product invented name | Pharmaceutical form | Strength | Animal species | Frequency and route of administration | Recommended dose |
| --- | --- | --- | --- | --- | --- | --- | --- |
| The Netherlands, Belgium, Germany, France, Italy, Spain and the United Kingdom | ACE Pharmaceuticals BV |
| Schepenveld 41 |
| 3891 ZK Zeewolde |
| Nederland |
| (31-36) 522 72 01 |
| (31-36) 522 90 96 |
| fs@ace-pharm.nl |

Member State

Applicant or Marketing Authorisation Holder

Product invented name

Pharmaceutical form

Strength

Animal species

Frequency and route of administration

Recommended dose

The Netherlands, Belgium, Germany, France, Italy, Spain and the United Kingdom

ACE Pharmaceuticals BV

Schepenveld 41

3891 ZK Zeewolde

Nederland

(31-36) 522 72 01

(31-36) 522 90 96

fs@ace-pharm.nl

Enurace 50

Tablets

50 mg

Female dogs

For oral administration only, to be administered with food

A starting dose of 2 mg ephedrine HCl per kg of bodyweight per day, divided in two oral doses is recommended

---

ANNEX II

LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTE OF ADMINISTRATION, APPLICANT, MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Applicant | Name | Strength | Pharmaceutical Form | Route of administration | Content
  (concentration) |
| --- | --- | --- | --- | --- | --- | --- | --- |
| The Netherlands | Hikma Farmacêutica (Portugal), Lda. |
| Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença |
| P-2705-906 Terrugem SNT |

Member State

Marketing Authorisation Holder

Applicant

Name

Strength

Pharmaceutical Form

Route of administration

Content

(concentration)

The Netherlands

Hikma Farmacêutica (Portugal), Lda.

Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença

P-2705-906 Terrugem SNT

Ciprofloxacin Hikma 200 mg/100 ml Oplossing voor Intraveneuze Infusie

2 mg/ml

Solution for infusion

Intravenous use

200 mg/100 ml

Austria

| Hikma Farmacêutica (Portugal), Lda. |
| --- |
| Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença |
| P-2705-906 Terrugem SNT |

Hikma Farmacêutica (Portugal), Lda.

Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença

P-2705-906 Terrugem SNT

Ciprofloxacin Hikma 200 mg/100 ml Infusionslösung

2 mg/ml

Solution for infusion

Intravenous use

200 mg/100 ml

Germany

| Hikma Farmacêutica (Portugal), Lda. |
| --- |
| Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença |
| P-2705-906 Terrugem SNT |

Hikma Farmacêutica (Portugal), Lda.

Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença

P-2705-906 Terrugem SNT

Ciprofloxacin Hikma 200 mg/100 ml Lösung zur intravenösen Anwendung

2 mg/ml

Solution for infusion

Intravenous use

200 mg/100 ml

Ireland

| Hikma Farmacêutica (Portugal), Lda. |
| --- |
| Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença |
| P-2705-906 Terrugem SNT |

Hikma Farmacêutica (Portugal), Lda.

Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença

P-2705-906 Terrugem SNT

Ciprofloxacin Hikma 200 mg/100 ml Solution for Infusion

2 mg/ml

Solution for infusion

Intravenous use

200 mg/100 ml

Italy

| Hikma Farmacêutica (Portugal), Lda. |
| --- |
| Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença |
| P-2705-906 Terrugem SNT |

Hikma Farmacêutica (Portugal), Lda.

Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença

P-2705-906 Terrugem SNT

Ciprofloxacin Hikma 200 mg/100 ml Soluzione per Infusione Endovenosa

2 mg/ml

Solution for infusion

Intravenous use

200 mg/100 ml

United Kingdom

| Hikma Farmacêutica (Portugal), Lda. |
| --- |
| Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença |
| P-2705-906 Terrugem SNT |

Hikma Farmacêutica (Portugal), Lda.

Estrada do Rio da Mó n.o 8, 8A e 8B — Fervença

P-2705-906 Terrugem SNT

Ciprofloxacin Hikma 200 mg/100 ml Solution for Infusion

2 mg/ml

Solution for infusion

Intravenous use

200 mg/100 ml

---

ANNEX III

LIST OF THE NAMES, PHARMACEUTICAL FORM, STRENGTH OF THE MEDICINAL PRODUCT, ROUTE OF ADMINISTRATION, APPLICANT AND MARKETING AUTHORISATION HOLDER IN THE MEMBER STATES

| Member State | Marketing Authorisation Holder | Applicant | Invented name | Strength | Pharmaceutical form | Route of administration | Content
  (concentration) |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Denmark | Valera Pharmaceuticals Ireland Ltd |
| 25-28 North Wall Quay |
| Dublin |
| Ireland |

Member State

Marketing Authorisation Holder

Applicant

Invented name

Strength

Pharmaceutical form

Route of administration

Content

(concentration)

Denmark

Valera Pharmaceuticals Ireland Ltd

25-28 North Wall Quay

Dublin

Ireland

Vantas

50 mg

Implant

Subcutaneous

50 mg

Germany

| Valera Pharmaceuticals Ireland Ltd |
| --- |
| 25-28 North Wall Quay |
| Dublin |
| Ireland |

Valera Pharmaceuticals Ireland Ltd

25-28 North Wall Quay

Dublin

Ireland

Vantas

50 mg

Implant

Subcutaneous

50 mg

Ireland

| Valera Pharmaceuticals Ireland Ltd |
| --- |
| 25-28 North Wall Quay |
| Dublin |
| Ireland |

Valera Pharmaceuticals Ireland Ltd

25-28 North Wall Quay

Dublin

Ireland

Vantas

50 mg

Implant

Subcutaneous

50 mg

Italy

| Valera Pharmaceuticals Ireland Ltd |
| --- |
| 25-28 North Wall Quay |
| Dublin |
| Ireland |

Valera Pharmaceuticals Ireland Ltd

25-28 North Wall Quay

Dublin

Ireland

Vantas

50 mg

Implant

Subcutaneous

50 mg

Spain

| Valera Pharmaceuticals Ireland Ltd |
| --- |
| 25-28 North Wall Quay |
| Dublin |
| Ireland |

Valera Pharmaceuticals Ireland Ltd

25-28 North Wall Quay

Dublin

Ireland

Vantas

50 mg

Implant

Subcutaneous

50 mg

United Kingdom

| Valera Pharmaceuticals Ireland Ltd |
| --- |
| 25-28 North Wall Quay |
| Dublin |
| Ireland |

Valera Pharmaceuticals Ireland Ltd

25-28 North Wall Quay

Dublin

Ireland

Vantas

50 mg

Implant

Subcutaneous

50 mg

---

V Announcements

ADMINISTRATIVE PROCEDURES

European Parliament

| 31.8.2007 | EN | Official Journal of the European Union | C 203/14 |
| --- | --- | --- | --- |

31.8.2007

EN

Official Journal of the European Union

C 203/14

---

Recruitment notice PE/110/S

(2007/C 203/05)

The European Parliament is organising the following selection procedure:

PE/110/S — Temporary staff — Assistant (AST2) — Photographer.

This selection procedure requires a level of post-secondary education of at least two years attested by a diploma in the field of photography

or

a level of secondary education attested by a diploma giving access to post-secondary education followed by appropriate professional experience of at least three years in a field relevant to the job description.

By the closing date for applications candidates must, after obtaining the qualifications mentioned, have acquired at least three years' experience in a field relevant to the job description.

This recruitment notice is published only in English, French and German. The full text is in Official Journal C 203 A in the three languages.

---

PROCEDURES RELATING TO THE IMPLEMENTATION OF THE COMPETITION POLICY

Commission

| 31.8.2007 | EN | Official Journal of the European Union | C 203/15 |
| --- | --- | --- | --- |

31.8.2007

EN

Official Journal of the European Union

C 203/15

---

Notice from the Government of Romania concerning Directive 94/22/EC of the European Parliament and of the Council on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons

(Text with EEA relevance)

(2007/C 203/06)

Announcement of the 8th round of the invitation to tender in Romania

| 1. | On the basis of Article 3(2)(a) of Directive 94/22/EC of the European Parliament and of the Council of 30 May 1994 on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons (1), the National Agency for Mineral Resources, the Competent Authority as laid down in Article 10 of Directive 94/22/EC, hereby invites all interested parties to submit applications for oil concession agreements as part of the 8th round of the invitation to tender. |
| --- | --- |

1.

On the basis of Article 3(2)(a) of Directive 94/22/EC of the European Parliament and of the Council of 30 May 1994 on the conditions for granting and using authorisations for the prospection, exploration and production of hydrocarbons (1), the National Agency for Mineral Resources, the Competent Authority as laid down in Article 10 of Directive 94/22/EC, hereby invites all interested parties to submit applications for oil concession agreements as part of the 8th round of the invitation to tender.

| 2. | The 8th round of the invitation to tender is organised by the National Agency for Mineral Resources in accordance with Law No 238/2004 on oil and the Implementing Rules for Law No 238/2004 on oil, approved by Government Decision No 2075/2004, amended and supplemented by Government Decision No 350/2007. |
| --- | --- |

2.

The 8th round of the invitation to tender is organised by the National Agency for Mineral Resources in accordance with Law No 238/2004 on oil and the Implementing Rules for Law No 238/2004 on oil, approved by Government Decision No 2075/2004, amended and supplemented by Government Decision No 350/2007.

| 3. | The purpose of the 8th round of the invitation to tender is to conclude agreements for the exploration and subsequent production of hydrocarbons for the nine exploration areas listed in Table 1, and to conclude operating agreements for the production of hydrocarbons from the 26 national areas listed in Table 2.
  Table 1
  EXPLORATION AREAS UP FOR TENDER








  No | AREA | COORDINATES | STEREO 70 |
| --- | --- | --- | --- | --- |
| X | Y |
| 1 | E VIII — 1 BOTOŞANI | 743.455 | 598.902 |
| 749.070 | 634.736 |
| 739.013 | 644.735 |
| 728.688 | 649.160 |
| 719.464 | 614.339 |
| 2 | E VIII — 1 DOROHOI | 719.464 | 614.339 |
| 728.687 | 649.160 |
| 703.989 | 661.063 |
| 692.004 | 632.040 |
| 3 | E VIII — 3 HÂRLĂU | 692.005 | 632.040 |
| 703.990 | 661.063 |
| 687.505 | 671.896 |
| 679.370 | 678.189 |
| 666.370 | 648.555 |
| 4 | E VIII — 4 PRUT | 666.370 | 648555 |
| 679.370 | 678189 |
| 654990 | 694115 |
| 639.354 | 665.959 |
| 5 | E VIII — 5 IAŞI | 639.354 | 665.959 |
| 654.990 | 694.115 |
| 650.403 | 694.592 |
| 628.335 | 711.056 |
| 614.971 | 687.432 |
| 6 | E VIII — 6 SIRET | 614971 | 687.432 |
| 628.335 | 711.056 |
| 612.675 | 731.602 |
| 605.945 | 733.223 |
| 588.127 | 711.064 |
| 7 | EVIII — 7 HUŞI | 588.127 | 711.064 |
| 605.945 | 733.223 |
| 576.797 | 745.578 |
| 547.367 | 746.950 |
| 8 | E VIII — 8 EST DEPRESIUNEA PANNONICĂ | 347.700 | 644.000 |
| 332.369 | 618.539 |
| 317.617 | 630.962 |
| 290.130 | 603.320 |
| 297502 | 590615 |
| 291.217 | 578.630 |
| 280.347 | 583.288 |
| 272.272 | 575.834 |
| 284.990 | 555.354 |
| 251.000 | 548.000 |
| 244.047 | 549.307 |
| 306.000 | 626.000 |
| 306.000 | 632.500 |
| 308.000 | 632.500 |
| 308.000 | 640.000 |
| 317.500 | 640.000 |
| 317.500 | 632.000 |
| 327.000 | 632.000 |
| 327.000 | 644.000 |
| 9 | E VIII — 9 ANINA | 430.673 | 255.771 |
| 426.572 | 266.078 |
| 384.444 | 252.657 |
| 384.971 | 239.503 |

3.

The purpose of the 8th round of the invitation to tender is to conclude agreements for the exploration and subsequent production of hydrocarbons for the nine exploration areas listed in Table 1, and to conclude operating agreements for the production of hydrocarbons from the 26 national areas listed in Table 2.

Table 1

EXPLORATION AREAS UP FOR TENDER

No

AREA

COORDINATES

STEREO 70

X

Y

1

E VIII — 1 BOTOŞANI

743.455

598.902

749.070

634.736

739.013

644.735

728.688

649.160

719.464

614.339

2

E VIII — 1 DOROHOI

719.464

614.339

728.687

649.160

703.989

661.063

692.004

632.040

3

E VIII — 3 HÂRLĂU

692.005

632.040

703.990

661.063

687.505

671.896

679.370

678.189

666.370

648.555

4

E VIII — 4 PRUT

666.370

648555

679.370

678189

654990

694115

639.354

665.959

5

E VIII — 5 IAŞI

639.354

665.959

654.990

694.115

650.403

694.592

628.335

711.056

614.971

687.432

6

E VIII — 6 SIRET

614971

687.432

628.335

711.056

612.675

731.602

605.945

733.223

588.127

711.064

7

EVIII — 7 HUŞI

588.127

711.064

605.945

733.223

576.797

745.578

547.367

746.950

8

E VIII — 8 EST DEPRESIUNEA PANNONICĂ

347.700

644.000

332.369

618.539

317.617

630.962

290.130

603.320

297502

590615

291.217

578.630

280.347

583.288

272.272

575.834

284.990

555.354

251.000

548.000

244.047

549.307

306.000

626.000

306.000

632.500

308.000

632.500

308.000

640.000

317.500

640.000

317.500

632.000

327.000

632.000

327.000

644.000

9

E VIII — 9 ANINA

430.673

255.771

426.572

266.078

384.444

252.657

384.971

239.503

Table 2

OPERATION AREAS UP FOR TENDER

| No | AREA | COUNTY | TYPE OF HYDROCARBON | DEMARCATION |
| --- | --- | --- | --- | --- |
| COORDINATES | DEPTH INTERVAL |
| STEREO 70 | DEPTH CONTOUR |
| (m) |
| 1 | P VIII — 1 ALĂMOR VEST | SIBIU | Non-associated natural gas | X | Y | Unlimited |
| 495795,56 | 418466,27 |
| 495368,91 | 418760,31 |
| 495147,70 | 418479,25 |
| 495578,80 | 418186,53 |
| 2 | P VIII — 2 ARPĂŞEL | TIMIŞ | Non-associated natural gas | X | Y | Unlimited |
| 590403,90 | 247500,61 |
| 588790,10 | 250795,94 |
| 588273,02 | 251050,01 |
| 587665,78 | 250779,54 |
| 588806,49 | 248087,59 |
| 589200,64 | 247300,04 |
| 589615,35 | 247250,82 |
| 3 | P VIII — 3 BOGEIU | BIHOR | Oil | X | Y | Unlimited |
| 642551,45 | 298228,60 |
| 642629,47 | 298364,88 |
| 642704,36 | 298660,64 |
| 642725,61 | 299522,17 |
| 642628,28 | 299643,70 |
| 642321,42 | 299669,90 |
| 642235,23 | 299396,43 |
| 642273,72 | 298326,18 |
| 4 | P VIII — 4 CHEŢ | BIHOR | Oil + associated natural gas | X | Y | Unlimited |
| 660582,22 | 296046,62 |
| 661135,42 | 297317,42 |
| 660249,82 | 297613,82 |
| 659003,02 | 297112,82 |
| 659604,22 | 296034,62 |
| 5 | P VIII — 5 CIUTELEC | BIHOR | Oil | X | Y | Unlimited |
| 644987,70 | 302148,83 |
| 644337,72 | 303866,10 |
| 645476,45 | 303866,10 |
| 645612,20 | 302658,78 |
| 645189,05 | 302235,63 |
| 6 | P VIII — 6 COPĂCENI | GIURGIU | Non-associated natural gas | X | Y | Unlimited |
| 309190,55 | 586588,74 |
| 309864,35 | 587098,92 |
| 310134,13 | 588294,74 |
| 309723,97 | 589443,62 |
| 7 | P VIII — 7 DIENCI | OLT | Non-associated natural gas | X | Y | Unlimited |
| 362413,85 | 451809,79 |
| 362902,43 | 453186,67 |
| 362678,82 | 453785,4 |
| 361877,87 | 454355,58 |
| 360695,69 | 453244,14 |
| 360942,55 | 452299,18 |
| 8 | P VIII — 8 DINDEŞTI | SATU MARE | Non-associated natural gas | X | Y | (-1200)-(-1350) |
| 677089,60 | 301997,71 |
| 677255,45 | 300851,22 |
| 678323,47 | 301068,99 |
| 678757,59 | 302000,04 |
| 678639,86 | 302680,76 |
| 677618,92 | 302670,21 |
| 9 | P VIII — 9 DOLANI — TĂTĂRANI | DÂMBOVIŢA | Non-associated natural gas | X | Y | Unlimited |
| 389122,80 | 524438,64 |
| 388902,52 | 525593,80 |
| 389308,85 | 529636,99 |
| 389797,36 | 529924,07 |
| 389958,37 | 524981,93 |
| 10 | P VIII — 10 FIERBINŢI TÂRG | IALOMIŢA | Oil + associated natural gas | X | Y | Unlimited |
| 349838,15 | 611515,52 |
| 349700,00 | 613700,00 |
| 351600,00 | 617400,00 |
| 352261,40 | 617480,00 |
| 11 | P VIII — 11 GLIGANU | ARGEŞ | Oil + associated natural gas | X | Y | Unlimited |
| 347755,22 | 505003,46 |
| 346096,52 | 505159,99 |
| 346135,37 | 506298,11 |
| 346626,15 | 508745,52 |
| 347104,79 | 508759,87 |
| 347906,06 | 507042,92 |
| 12 | P VIII — 12 GORNENI | GIURGIU | Non-associated natural gas | X | Y | Unlimited |
| 311202,02 | 570821,99 |
| 311660,83 | 571501,49 |
| 311960,18 | 572441,57 |
| 311781,50 | 573352,14 |
| 311781,50 | 573850,00 |
| 311780,00 | 573352,00 |
| 311242,55 | 572474,84 |
| 310629,84 | 570751,57 |
| 13 | P VIII — 13 GRĂNICERI | TIMIŞ | Non-associated natural gas | X | Y | Unlimited |
| 444800,00 | 180000,00 |
| 444000,00 | 180000,00 |
| 444000,00 | 181000,00 |
| 445000,00 | 181000,00 |
| 14 | P VIII — 14 GRIVIŢA | GALAŢI | Oil + associated natural gas + non-associated natural gas | X | Y | Unlimited |
| 481362,49 | 702951,15 |
| 479529,88 | 703374,06 |
| 478862,37 | 703816,78 |
| 479651,80 | 704483,53 |
| 482370,62 | 704402,00 |
| 15 | P VIII — 15 MELINEŞTI | DOLJ | Oil + associated natural gas | X | Y | Unlimited |
| 338458,48 | 398293,96 |
| 338404,06 | 400402,28 |
| 337937,28 | 400605,22 |
| 337460,01 | 399839,80 |
| 337203,67 | 399329,53 |
| 338199,52 | 398340,95 |
| 16 | P VII — 16 OPORELU — CONSTANTINEŞTI | OLT | Oil + associated natural gas + non-associated natural gas | X | Y | (-1000)-(-3200) |
| 343126,08 | 449695,66 |
| 345650,29 | 455366,44 |
| 345625,80 | 460817,28 |
| 346939,19 | 462401,47 |
| 345426,80 | 464039,49 |
| 344814,50 | 461266,39 |
| 343773,59 | 459245,40 |
| 344023,10 | 457356,67 |
| 342138,74 | 456658,40 |
| 339366,55 | 451324,45 |
| 339599,22 | 449380,36 |
| 341460,62 | 448935,86 |
| 17 | P VIII — 17 PÂRÂIENI | VÂLCEA | Non-associated natural gas | X | Y | (-1300)-(-1520) |
| 367509,39 | 408189,22 |
| 367878,36 | 408516,36 |
| 367855,59 | 409078,51 |
| 367545,50 | 409396,37 |
| 366681,30 | 409408,91 |
| 366335,48 | 409041,91 |
| 366355,81 | 408515,23 |
| 366785,12 | 408142,05 |
| 18 | P VII — 18 POSTĂVARI | CĂLĂRAŞI | Non-associated natural gas | X | Y | Unlimited |
| 314109,82 | 598225,19 |
| 315327,45 | 599079,30 |
| 315855,79 | 600198,22 |
| 315075,53 | 602298,63 |
| 314732,13 | 602323,21 |
| 314032,34 | 600798,05 |
| 313585,47 | 598225,19 |
| 19 | P VIII — 19 SALACEA | BIHOR | Non-associated natural gas + condensed gas | X | Y | Unlimited |
| 665170,49 | 295031,62 |
| 667812,65 | 295049,27 |
| 667839,13 | 297048,44 |
| 666220,59 | 297010,52 |
| 20 | P VIII — 20 SĂCEL | MARAMUREŞ | Oil + associated natural gas | X | Y | (0)-(-1600) |
| 682431,70 | 455159,85 |
| 681152,19 | 455431,63 |
| 680917,10 | 457095,65 |
| 681133,79 | 458044,27 |
| 682001,69 | 458771,64 |
| 683194,82 | 455903,70 |
| 682987,89 | 455234,72 |
| 21 | P VIII — 21 SĂLIŞTE | BIHOR | Oil + associated natural gas | X | Y | (0)-(-1400) |
| 685120,40 | 450205,37 |
| 685232,22 | 450666,89 |
| 685312,73 | 451267,56 |
| 684812,36 | 451196,42 |
| 684699,88 | 450627,63 |
| 684652,68 | 450183,00 |
| 22 | P VIII — 22 SÂNIOB | BIHOR | Oil + associated natural gas | X | Y | Unlimited |
| 646185,22 | 281117,39 |
| 647441,20 | 284365,43 |
| 645180,72 | 284737,54 |
| 643726,30 | 285659,72 |
| 643582,03 | 283212,95 |
| 644068,70 | 280114,74 |
| 23 | P VII — 22 SĂRVĂZEL | SATU MARE | Non-associated natural gas + condensed gas | X | Y | Unlimited |
| 662400,00 | 303500,00 |
| 660700,00 | 304700,00 |
| 661300,00 | 305100,00 |
| 662400,00 | 304300,00 |
| 24 | P VIII — 24 SILIŞTEA — MĂGURENI | VÂLCEA | Oil + associated natural gas + non-associated natural gas | X | Y | (0)-(-800) |
| 389932,79 | 552835,31 |
| 391254,70 | 558920,41 |
| 392452,97 | 558837,99 |
| 391062,03 | 552587,00 |
| 25 | P VIII — 25 STOIENIŢA | GORJ | Oil + associated natural gas + non-associated natural gas + condensed gas | X | Y | (-3300)-(4350) |
| 355359,96 | 390779,90 |
| 354799,81 | 391280,13 |
| 355179,20 | 393280,23 |
| 355639,02 | 393423,74 |
| 356372,22 | 393321,41 |
| 356310,07 | 391579,37 |
| 26 | P VIII — 26 SUDURĂU | SATU MARE | Oil + associated natural gas | X | Y | Unlimited |
| 673917,25 | 307634,02 |
| 672524,65 | 307648,03 |
| 671917,84 | 308578,76 |
| 673280,52 | 309255,13 |
| 673717,43 | 308659,37 |

No

AREA

COUNTY

TYPE OF HYDROCARBON

DEMARCATION

COORDINATES

DEPTH INTERVAL

STEREO 70

DEPTH CONTOUR

(m)

1

P VIII — 1 ALĂMOR VEST

SIBIU

Non-associated natural gas

X

Y

Unlimited

495795,56

418466,27

495368,91

418760,31

495147,70

418479,25

495578,80

418186,53

2

P VIII — 2 ARPĂŞEL

TIMIŞ

Non-associated natural gas

X

Y

Unlimited

590403,90

247500,61

588790,10

250795,94

588273,02

251050,01

587665,78

250779,54

588806,49

248087,59

589200,64

247300,04

589615,35

247250,82

3

P VIII — 3 BOGEIU

BIHOR

Oil

X

Y

Unlimited

642551,45

298228,60

642629,47

298364,88

642704,36

298660,64

642725,61

299522,17

642628,28

299643,70

642321,42

299669,90

642235,23

299396,43

642273,72

298326,18

4

P VIII — 4 CHEŢ

BIHOR

Oil + associated natural gas

X

Y

Unlimited

660582,22

296046,62

661135,42

297317,42

660249,82

297613,82

659003,02

297112,82

659604,22

296034,62

5

P VIII — 5 CIUTELEC

BIHOR

Oil

X

Y

Unlimited

644987,70

302148,83

644337,72

303866,10

645476,45

303866,10

645612,20

302658,78

645189,05

302235,63

6

P VIII — 6 COPĂCENI

GIURGIU

Non-associated natural gas

X

Y

Unlimited

309190,55

586588,74

309864,35

587098,92

310134,13

588294,74

309723,97

589443,62

7

P VIII — 7 DIENCI

OLT

Non-associated natural gas

X

Y

Unlimited

362413,85

451809,79

362902,43

453186,67

362678,82

453785,4

361877,87

454355,58

360695,69

453244,14

360942,55

452299,18

8

P VIII — 8 DINDEŞTI

SATU MARE

Non-associated natural gas

X

Y

(-1200)-(-1350)

677089,60

301997,71

677255,45

300851,22

678323,47

301068,99

678757,59

302000,04

678639,86

302680,76

677618,92

302670,21

9

P VIII — 9 DOLANI — TĂTĂRANI

DÂMBOVIŢA

Non-associated natural gas

X

Y

Unlimited

389122,80

524438,64

388902,52

525593,80

389308,85

529636,99

389797,36

529924,07

389958,37

524981,93

10

P VIII — 10 FIERBINŢI TÂRG

IALOMIŢA

Oil + associated natural gas

X

Y

Unlimited

349838,15

611515,52

349700,00

613700,00

351600,00

617400,00

352261,40

617480,00

11

P VIII — 11 GLIGANU

ARGEŞ

Oil + associated natural gas

X

Y

Unlimited

347755,22

505003,46

346096,52

505159,99

346135,37

506298,11

346626,15

508745,52

347104,79

508759,87

347906,06

507042,92

12

P VIII — 12 GORNENI

GIURGIU

Non-associated natural gas

X

Y

Unlimited

311202,02

570821,99

311660,83

571501,49

311960,18

572441,57

311781,50

573352,14

311781,50

573850,00

311780,00

573352,00

311242,55

572474,84

310629,84

570751,57

13

P VIII — 13 GRĂNICERI

TIMIŞ

Non-associated natural gas

X

Y

Unlimited

444800,00

180000,00

444000,00

180000,00

444000,00

181000,00

445000,00

181000,00

14

P VIII — 14 GRIVIŢA

GALAŢI

Oil + associated natural gas + non-associated natural gas

X

Y

Unlimited

481362,49

702951,15

479529,88

703374,06

478862,37

703816,78

479651,80

704483,53

482370,62

704402,00

15

P VIII — 15 MELINEŞTI

DOLJ

Oil + associated natural gas

X

Y

Unlimited

338458,48

398293,96

338404,06

400402,28

337937,28

400605,22

337460,01

399839,80

337203,67

399329,53

338199,52

398340,95

16

P VII — 16 OPORELU — CONSTANTINEŞTI

OLT

Oil + associated natural gas + non-associated natural gas

X

Y

(-1000)-(-3200)

343126,08

449695,66

345650,29

455366,44

345625,80

460817,28

346939,19

462401,47

345426,80

464039,49

344814,50

461266,39

343773,59

459245,40

344023,10

457356,67

342138,74

456658,40

339366,55

451324,45

339599,22

449380,36

341460,62

448935,86

17

P VIII — 17 PÂRÂIENI

VÂLCEA

Non-associated natural gas

X

Y

(-1300)-(-1520)

367509,39

408189,22

367878,36

408516,36

367855,59

409078,51

367545,50

409396,37

366681,30

409408,91

366335,48

409041,91

366355,81

408515,23

366785,12

408142,05

18

P VII — 18 POSTĂVARI

CĂLĂRAŞI

Non-associated natural gas

X

Y

Unlimited

314109,82

598225,19

315327,45

599079,30

315855,79

600198,22

315075,53

602298,63

314732,13

602323,21

314032,34

600798,05

313585,47

598225,19

19

P VIII — 19 SALACEA

BIHOR

Non-associated natural gas + condensed gas

X

Y

Unlimited

665170,49

295031,62

667812,65

295049,27

667839,13

297048,44

666220,59

297010,52

20

P VIII — 20 SĂCEL

MARAMUREŞ

Oil + associated natural gas

X

Y

(0)-(-1600)

682431,70

455159,85

681152,19

455431,63

680917,10

457095,65

681133,79

458044,27

682001,69

458771,64

683194,82

455903,70

682987,89

455234,72

21

P VIII — 21 SĂLIŞTE

BIHOR

Oil + associated natural gas

X

Y

(0)-(-1400)

685120,40

450205,37

685232,22

450666,89

685312,73

451267,56

684812,36

451196,42

684699,88

450627,63

684652,68

450183,00

22

P VIII — 22 SÂNIOB

BIHOR

Oil + associated natural gas

X

Y

Unlimited

646185,22

281117,39

647441,20

284365,43

645180,72

284737,54

643726,30

285659,72

643582,03

283212,95

644068,70

280114,74

23

P VII — 22 SĂRVĂZEL

SATU MARE

Non-associated natural gas + condensed gas

X

Y

Unlimited

662400,00

303500,00

660700,00

304700,00

661300,00

305100,00

662400,00

304300,00

24

P VIII — 24 SILIŞTEA — MĂGURENI

VÂLCEA

Oil + associated natural gas + non-associated natural gas

X

Y

(0)-(-800)

389932,79

552835,31

391254,70

558920,41

392452,97

558837,99

391062,03

552587,00

25

P VIII — 25 STOIENIŢA

GORJ

Oil + associated natural gas + non-associated natural gas + condensed gas

X

Y

(-3300)-(4350)

355359,96

390779,90

354799,81

391280,13

355179,20

393280,23

355639,02

393423,74

356372,22

393321,41

356310,07

391579,37

26

P VIII — 26 SUDURĂU

SATU MARE

Oil + associated natural gas

X

Y

Unlimited

673917,25

307634,02

672524,65

307648,03

671917,84

308578,76

673280,52

309255,13

673717,43

308659,37

Complete information concerning the offer, access to data and geological information and the payment of fees are presented in the ‘Tender process for the concession of oil operations’, which is available on the website of the National Agency for Mineral Resources: www.namr.ro. To obtain a copy of this document, please send a written request. The legislative acts mentioned above can also be consulted on the website.

| 4. | Interested Romanian and foreign legal persons should submit in writing their bids for the exploration areas listed in Table 1 in Romanian to:





  Agenţia Naţională pentru Resurse Minerale |
| --- | --- |
| În atenţia Bogdan Gabudeanu, Preşedinte |
| Str. Mendeleev nr. 36-38, cod 010366, sector 1 |
| Bucureşti |
| Romania |

4.

Interested Romanian and foreign legal persons should submit in writing their bids for the exploration areas listed in Table 1 in Romanian to:

Agenţia Naţională pentru Resurse Minerale

În atenţia Bogdan Gabudeanu, Preşedinte

Str. Mendeleev nr. 36-38, cod 010366, sector 1

Bucureşti

Romania

by 15.00 on the final day of the period of 100 working days starting from the first day after the publication of this notice in the Official Journal of the European Union.

Bids for the operation areas listed in Table 2 should be submitted by 15.00 on the final day of the period of 120 working days starting from the first day after the publication of this notice in the Official Journal of the European Union.

Bids submitted after the deadline will not be considered.

The bids will be opened at a public meeting at 10.00 on the first working day after the deadline mentioned above.

| 5. | The bids should include the data and information specified in Articles 32 to 35 of the Implementing Rules for Law No 238/2004 on oil, approved by Government Decision No 2075/2004.
  When drawing up their bids, interested legal persons can access the data and geological information made available by the National Agency for Mineral Resources in accordance with Article 24(3)(c) to (g) of the Implementing Rules for Law No 238/2004 on oil, approved by Government Decision No 2075/2004.
  The data and geological information can be accessed by sending a written request addressed to the Chairman of the National Agency for Mineral Resources, after the signature of a confidentiality agreement and the payment of the legal fees for the acquisition of the set of data and of the fees for consultation and use of information belonging to the National Geological Data Fund. |
| --- | --- |

5.

The bids should include the data and information specified in Articles 32 to 35 of the Implementing Rules for Law No 238/2004 on oil, approved by Government Decision No 2075/2004.

When drawing up their bids, interested legal persons can access the data and geological information made available by the National Agency for Mineral Resources in accordance with Article 24(3)(c) to (g) of the Implementing Rules for Law No 238/2004 on oil, approved by Government Decision No 2075/2004.

The data and geological information can be accessed by sending a written request addressed to the Chairman of the National Agency for Mineral Resources, after the signature of a confidentiality agreement and the payment of the legal fees for the acquisition of the set of data and of the fees for consultation and use of information belonging to the National Geological Data Fund.

| 6. | The provisions and criteria as specified in Article 5(1) of Directive 94/22/EC for assessing the bids and the technical and financial capacity of the bidders are laid down in the Implementing Rules for Law No 238/2004 on oil, approved by Government Decision No 2075/2004, published in Official Gazette of Romania No 1170 of 10 December 2004, Part I, amended and supplemented by Government Decision No 350/2007, published in Official Gazette of Romania No 272 of 24 April 2007, Part I. |
| --- | --- |

6.

The provisions and criteria as specified in Article 5(1) of Directive 94/22/EC for assessing the bids and the technical and financial capacity of the bidders are laid down in the Implementing Rules for Law No 238/2004 on oil, approved by Government Decision No 2075/2004, published in Official Gazette of Romania No 1170 of 10 December 2004, Part I, amended and supplemented by Government Decision No 350/2007, published in Official Gazette of Romania No 272 of 24 April 2007, Part I.

| 7. | The decision on the bids will be taken by the National Agency for Mineral Resources within 30 working days of the date the bids are opened and will be communicated to all the bidders. |
| --- | --- |

7.

The decision on the bids will be taken by the National Agency for Mineral Resources within 30 working days of the date the bids are opened and will be communicated to all the bidders.

| 8. | Negotiations with the successful bidders will commence within 15 days of the date the successful bid was announced, provided that no challenges of the result have been submitted.
  It is expected that oil concession agreements between the National Agency for Mineral Resources and the successful bidders will be signed within six months of the start of negotiations.
  The oil agreement will enter into force after approval by government decision. |
| --- | --- |

8.

Negotiations with the successful bidders will commence within 15 days of the date the successful bid was announced, provided that no challenges of the result have been submitted.

It is expected that oil concession agreements between the National Agency for Mineral Resources and the successful bidders will be signed within six months of the start of negotiations.

The oil agreement will enter into force after approval by government decision.

| 9. | The conditions and requirements relating to the performance and termination of the activity are laid down in Law No 238/2004 on oil, published in Official Gazette No 535 of 15 June 2004, Part I. |
| --- | --- |

9.

The conditions and requirements relating to the performance and termination of the activity are laid down in Law No 238/2004 on oil, published in Official Gazette No 535 of 15 June 2004, Part I.

| 10. | Further information can be obtained from the following sources:






  — | the website of the National Agency for Mineral Resources: www.namr.ro |
| --- | --- | --- |

10.

Further information can be obtained from the following sources:

—

the website of the National Agency for Mineral Resources: www.namr.ro

| — | Mr Gicu Boroşi, Director-General, Tel. (40) 21 317 01 84, e-mail: gicu.borosi@namr.ro |
| --- | --- |

—

Mr Gicu Boroşi, Director-General, Tel. (40) 21 317 01 84, e-mail: gicu.borosi@namr.ro

| — | Mr Mihai German, Deputy Director-General, Tel. (40) 21 317 00 96, e-mail: mihai.german@namr.ro |
| --- | --- |

—

Mr Mihai German, Deputy Director-General, Tel. (40) 21 317 00 96, e-mail: mihai.german@namr.ro

---

(1)  OJ L 164, 30.6.1994, p. 3.

---

| 31.8.2007 | EN | Official Journal of the European Union | C 203/25 |
| --- | --- | --- | --- |

31.8.2007

EN

Official Journal of the European Union

C 203/25

---

Prior notification of a concentration

(Case COMP/M.4866 — Arques/Actebis)

(Text with EEA relevance)

(2007/C 203/07)

| 1. | On 24 August 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Arques Industries AG (‘Arques’, Germany) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertakings Actebis Peacock GmbH & Co. KG (Germany), Beteiligungsgesellschaft Actebis Peacock mbH (Germany), Actebis S.A.S. (France), Logiciels Applications Formation S.A.S. (France), Actebis Computerhandels GmbH (Austria) and Actebis Computers B.V. (Netherlands) (‘Actebis target companies’) by way of purchase of shares. |
| --- | --- |

1.

On 24 August 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Arques Industries AG (‘Arques’, Germany) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertakings Actebis Peacock GmbH & Co. KG (Germany), Beteiligungsgesellschaft Actebis Peacock mbH (Germany), Actebis S.A.S. (France), Logiciels Applications Formation S.A.S. (France), Actebis Computerhandels GmbH (Austria) and Actebis Computers B.V. (Netherlands) (‘Actebis target companies’) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for Arques and its affiliated companies: restructuring of companies; wholesale and resale of information technology products, assembling of information technology products, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for Arques and its affiliated companies: restructuring of companies; wholesale and resale of information technology products, assembling of information technology products,

| — | for the Actebis target companies: wholesale of information technology products. |
| --- | --- |

—

for the Actebis target companies: wholesale of information technology products.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4866 — Arques/Actebis, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4866 — Arques/Actebis, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

---

| 31.8.2007 | EN | Official Journal of the European Union | C 203/26 |
| --- | --- | --- | --- |

31.8.2007

EN

Official Journal of the European Union

C 203/26

---

Prior notification of a concentration

(Case COMP/M.4713 — Aviva/Hamilton)

(Text with EEA relevance)

(2007/C 203/08)

| 1. | On 23 August 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Aviva Plc (‘Aviva’, UK) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertakings Hamilton Insurance Company Limited (‘Hamilton General’, UK) and Hamilton Life Assurance Company Limited (‘Hamilton Life’, UK) by way of purchase of shares. |
| --- | --- |

1.

On 23 August 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Aviva Plc (‘Aviva’, UK) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertakings Hamilton Insurance Company Limited (‘Hamilton General’, UK) and Hamilton Life Assurance Company Limited (‘Hamilton Life’, UK) by way of purchase of shares.

| 2. | The business activities of the undertakings concerned are:






  — | for undertaking Aviva: active in general insurance and life assurance, long term savings and fund management, |
| --- | --- | --- |

2.

The business activities of the undertakings concerned are:

—

for undertaking Aviva: active in general insurance and life assurance, long term savings and fund management,

| — | for undertaking Hamilton General: active in general insurance, |
| --- | --- |

—

for undertaking Hamilton General: active in general insurance,

| — | for undertaking Hamilton Life: active in life assurance. |
| --- | --- |

—

for undertaking Hamilton Life: active in life assurance.

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved. |
| --- | --- |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
  Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4713 — Aviva/Hamilton, to the following address:





  European Commission |
| --- | --- |
| Directorate-General for Competition |
| Merger Registry |
| J-70 |
| B-1049 Bruxelles/Brussel |

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4713 — Aviva/Hamilton, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel

---

(1)  OJ L 24, 29.1.2004, p. 1.

---